Single dose of LSD provides immediate, lasting anxiety relief, study says | CNN

The FDA has approved the use of LSD for anxiety without therapy. What do you think?
The FDA is expediting the development of LSD to treat anxiety. A single dose of the LSD formulation MM120 had a 48% rate of remission from generalized anxiety disorder after 12 weeks, the biotech company MindMed revealed yesterday. The positive clinical trial results were enough for the FDA to grant the drug breakthrough therapy status, which can lead to a fast-track approval. While psychedelics have long been used to treat mental illness in conjunction with psychotherapy, the MindMed study was the first to prove LSD can alleviate anxiety without the help of therapy. MindMed’s stock soared after reports of the encouraging trial.